169 related articles for article (PubMed ID: 33003960)
1. Investigation of the mucoadhesivity, swelling, and drug release mechanisms of indomethacin buccal tablets: effect of formulation variables.
Esim O; Savaser A; Ozkan CK; Tas C; Ozkan Y
Drug Dev Ind Pharm; 2020 Dec; 46(12):1979-1987. PubMed ID: 33003960
[TBL] [Abstract][Full Text] [Related]
2. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug.
Khan GM; Zhu JB
J Control Release; 1999 Feb; 57(2):197-203. PubMed ID: 9971903
[TBL] [Abstract][Full Text] [Related]
3. Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug.
Khan GM; Jiabi Z
J Control Release; 1998 Jul; 54(2):185-90. PubMed ID: 9724905
[TBL] [Abstract][Full Text] [Related]
4. Towards functional characterization of excipients for oral solid dosage forms using UV-vis imaging. Liberation, release and dissolution.
Li Z; Sun Y; Bar-Shalom D; Mu H; Larsen SW; Jensen H; Østergaard J
J Pharm Biomed Anal; 2021 Feb; 194():113789. PubMed ID: 33298380
[TBL] [Abstract][Full Text] [Related]
5. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
[TBL] [Abstract][Full Text] [Related]
6. Formulation, development and in vitro characterization of modified release tablets of capecitabine.
Gaikwad SS; Avhad RD; Kalkotwar RS
Drug Dev Ind Pharm; 2020 Jan; 46(1):20-30. PubMed ID: 31778085
[No Abstract] [Full Text] [Related]
7. Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation.
Kassem MA; Elmeshad AN; Fares AR
Int J Pharm; 2014 Mar; 463(1):68-80. PubMed ID: 24412520
[TBL] [Abstract][Full Text] [Related]
8. Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets.
Saurí J; Millán D; Suñé-Negre JM; Colom H; Ticó JR; Miñarro M; Pérez-Lozano P; García-Montoya E
Int J Pharm; 2014 Dec; 477(1-2):431-41. PubMed ID: 25445523
[TBL] [Abstract][Full Text] [Related]
9. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
10. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
[TBL] [Abstract][Full Text] [Related]
11. Statistical optimisation of the mucoadhesivity and characterisation of multipolymeric propranolol matrices for buccal therapy.
Munasur AP; Pillay V; Chetty DJ; Govender T
Int J Pharm; 2006 Oct; 323(1-2):43-51. PubMed ID: 16863686
[TBL] [Abstract][Full Text] [Related]
12. Use of spray-dried chitosan acetate and ethylcellulose as compression coats for colonic drug delivery: effect of swelling on triggering in vitro drug release.
Nunthanid J; Luangtana-anan M; Sriamornsak P; Limmatvapirat S; Huanbutta K; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2009 Feb; 71(2):356-61. PubMed ID: 18762255
[TBL] [Abstract][Full Text] [Related]
13. Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation.
Çelik B
Drug Des Devel Ther; 2017; 11():3355-3365. PubMed ID: 29225461
[TBL] [Abstract][Full Text] [Related]
14. Biointerfacial phenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: Correlation of swelling and drug delivery performance.
Panda B; Subhadarsini R; Mallick S
Expert Opin Drug Deliv; 2016; 13(5):633-43. PubMed ID: 26878690
[TBL] [Abstract][Full Text] [Related]
15. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
16. Pluronic-g-poly(acrylic acid) copolymers as novel excipients for site specific, sustained release tablets.
Barreiro-Iglesias R; Bromberg L; Temchenko M; Hatton TA; Alvarez-Lorenzo C; Concheiro A
Eur J Pharm Sci; 2005 Dec; 26(5):374-85. PubMed ID: 16165345
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol-loaded mucoadhesive buccal tablets: influence of various mucoadhesive polymers on drug release behavior.
Tamilvanan S; Bangale GS; Ananthi JJ; Sivakumar V; Vinothapooshan G; Palanivelu M; Viswanathan MB
PDA J Pharm Sci Technol; 2009; 63(3):196-206. PubMed ID: 20069792
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac.
Koirala S; Nepal P; Ghimire G; Basnet R; Rawat I; Dahal A; Pandey J; Parajuli-Baral K
Heliyon; 2021 Mar; 7(3):e06439. PubMed ID: 33786387
[TBL] [Abstract][Full Text] [Related]
20. Exploring the performance-controlling tablet disintegration mechanisms for direct compression formulations.
Maclean N; Walsh E; Soundaranathan M; Khadra I; Mann J; Williams H; Markl D
Int J Pharm; 2021 Apr; 599():120221. PubMed ID: 33540006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
